Abstract
Sulfonated carbon/silica composites derived from biomaterials viz. glucose, maltose, cellulose, chitosan and starch exhibited high catalytic activity for the one-pot synthesis of Hantzsch 1,4-dihydropyridines under solvent-free conditions, and for one-pot synthesis of 2,4,5-trisubstituted imidazoles and 2-arylbenzimidazoles under liquid phase catalysis. The activity of sulfonated carbon/silica composites derived from starch was found to be superior to other sulfonated carbon/ silica composites. The excellent conversions showed that the catalyst has strong and sufficient acidic sites, which are responsible for its catalytic performance. Moreover, these solid acid catalysts owned the advantages of high selectivity and recyclability.
Keywords: 2-arylben-zimidazoles, hantzsch 1, 4-dihydropyridines, sulfonated carbon/silica composites, solid acid catalysts, 2, 4, 5-trisubstituted imidazoles.
Current Catalysis
Title:Sulfonated Carbon/Silica Composites: Highly Efficient Heterogeneous Catalysts for the One-Pot Synthesis of Hantzsch 1,4-dihydropyridines, 2,4,5-trisubstituted Imidazoles and 2-arylbenzimidazoles
Volume: 3 Issue: 1
Author(s): Princy Gupta and Satya Paul
Affiliation:
Keywords: 2-arylben-zimidazoles, hantzsch 1, 4-dihydropyridines, sulfonated carbon/silica composites, solid acid catalysts, 2, 4, 5-trisubstituted imidazoles.
Abstract: Sulfonated carbon/silica composites derived from biomaterials viz. glucose, maltose, cellulose, chitosan and starch exhibited high catalytic activity for the one-pot synthesis of Hantzsch 1,4-dihydropyridines under solvent-free conditions, and for one-pot synthesis of 2,4,5-trisubstituted imidazoles and 2-arylbenzimidazoles under liquid phase catalysis. The activity of sulfonated carbon/silica composites derived from starch was found to be superior to other sulfonated carbon/ silica composites. The excellent conversions showed that the catalyst has strong and sufficient acidic sites, which are responsible for its catalytic performance. Moreover, these solid acid catalysts owned the advantages of high selectivity and recyclability.
Export Options
About this article
Cite this article as:
Gupta Princy and Paul Satya, Sulfonated Carbon/Silica Composites: Highly Efficient Heterogeneous Catalysts for the One-Pot Synthesis of Hantzsch 1,4-dihydropyridines, 2,4,5-trisubstituted Imidazoles and 2-arylbenzimidazoles, Current Catalysis 2014; 3 (1) . https://dx.doi.org/10.2174/22115447113029990015
DOI https://dx.doi.org/10.2174/22115447113029990015 |
Print ISSN 2211-5447 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5455 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Medical Treatment of COPD Patients with Mild and Moderate Airflow Obstruction
Current Respiratory Medicine Reviews Cardiovascular Imaging in Thromboembolic Risk Stratification for Atrial Fibrillation: Recent Patents and Current Practice
Recent Patents on Medical Imaging Pharmacological Interventions for the Prevention and Treatment of Kidney Injury Induced by Radiotherapy: Molecular Mechanisms and Clinical Perspectives
Current Molecular Pharmacology Mitochondrial Signaling and Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Implications
Current Pharmaceutical Design Altered Expression of microRNAs in Serum Extracellular Vesicles in Rats with Severe Burns during Shock Stage
Current Molecular Medicine The Complexities of TGF-β Action During Mammary and Squamous Cell Carcinogenesis
Current Pharmaceutical Biotechnology Cell-free DNA: Characteristics, Detection and its Applications in Myocardial Infarction
Current Pharmaceutical Design Biosurfactants as a Novel Additive in Pharmaceutical Formulations: Current Trends and Future Implications
Current Drug Metabolism Future Therapeutic Strategies in Inflammatory Cardiomyopathy: Insights from the Experimental Autoimmune Myocarditis Model
Cardiovascular & Hematological Disorders-Drug Targets Cardiovascular Effects of Green Tea Catechins: Progress and Promise
Recent Patents on Cardiovascular Drug Discovery von Willebrand Factor, von Willebrand Factor-Cleaving Protease, and Shear Stress
Cardiovascular & Hematological Agents in Medicinal Chemistry The In Silico Prediction of Human-Specific Metabolites from Hepatotoxic Drugs
Current Drug Discovery Technologies Serum Uric Acid and Risk of Coronary Heart Disease
Current Pharmaceutical Design CPP-Based Bioactive Drug Delivery to Penetrate the Blood-Brain Barrier: A Potential Therapy for Glioblastoma Multiforme
Current Drug Targets Editorial from Editor-in-Chief: Amniotic Pulmonary Embolism and the Respiratory System: Management Trends and Future Options
Current Respiratory Medicine Reviews Endothelial Function: A Surrogate Endpoint in Cardiovascular Studies?
Current Pharmaceutical Design Nutritional Status and Lipid Profile in HIV-Infected Adults
Endocrine, Metabolic & Immune Disorders - Drug Targets Physio-Pathological Consequences of Marginal or Severe Thiamin Deficiencies in Western Countries and the Potential of Cereal Products in Their Prevention
Current Nutrition & Food Science Value of Sodium-Glucose Co-Transporter 2 Inhibitor Versus Traditional Medication in Microalbuminuric Diabetic Patients
Current Diabetes Reviews Taurine Analogues; A New Class of Therapeutics: Retrospect and Prospects
Current Medicinal Chemistry